Skip to main content
SpringerLink
Log in

O

  • Chapter
Therapielexikon Neurologie

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 34.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Kosmorsky GS et al. (1995) The treatment of superior oblique myokymia utilizing the Harada-Ito procedure. J Neuroophthalmol; 15:142–6.

    PubMed  CAS  Google Scholar 

  2. Scharwey K et al. (2000) Remission of superior oblique myokymia after microvascular decompression. Ophthalmologica 214:426–8.

    Article  PubMed  CAS  Google Scholar 

  3. Brazis PW et al. (1994) The natural history and results of treatment of superior oblique myokymia. Arch Ophthalmol 112:1063–7.

    PubMed  CAS  Google Scholar 

Literatur

  1. Kraus JA, Koopmann J, Kaskel P et al. (1995) Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54:91–95.

    Article  PubMed  CAS  Google Scholar 

  2. Noble M, Gutowski N, Bevan K et al. (1995) From rodent glial precursor cell to human glial neoplasia in the oligodendrocyte-type-2 astrocyte lineage. Glia 15:222–23.

    Article  PubMed  CAS  Google Scholar 

  3. Kyritsis AP, Yung WK, Bruner J et al. (1993) The treatment of anaplastic oligodendrogliomas and mixed liomas. Neurosurgery 32:365–70.

    PubMed  CAS  Google Scholar 

Literatur

  1. Schlegel U, Westphal M (1998). Gliome. In: Schlegel U, Westphal M (Hrsg.) Neuroonkologie. Thieme, Stuttgart New York 170–203.

    Google Scholar 

  2. Mason WP, Krol GS, DeAngelis LM (1996). Low-grade oligodendroglioma responds to chemotherapy. Neurology 46:203–207.

    PubMed  CAS  Google Scholar 

  3. Kraus JA, Lamszus K, Glesmann N et al. (2001) Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathol (Berl) 101:311–320.

    PubMed  CAS  Google Scholar 

  4. van den Bent MJ, Kros JM, Heimans JJ et al. (1998). Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neurooncology Group. Neurology 51:1140–1146.

    PubMed  Google Scholar 

  5. Cairncross G, Macdonald D, Ludwin S et al. (1994) Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12:2013–2021.

    PubMed  CAS  Google Scholar 

  6. van Den Bent MJ, Keime-Guibert F, Brandes AA et al. (2001) Temozolomide chemotherapy in recurrent oligodendroglioma. Neurology 57:340–342.

    PubMed  Google Scholar 

  7. Olson JD, Riedel E, DeAngelis LM (2000). Longterm outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54:1442–1448.

    PubMed  CAS  Google Scholar 

Literatur

  1. Shapiro WR, Young DF, Mehta BM (1975). Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 293:161–166.

    PubMed  CAS  Google Scholar 

  2. Schlegel U, Pels H, Glasmacher A et al. (2001) Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study. J Neurol Neurosurg Psychiatry 71:118–22.

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Caldeira JA (2000). Vertical transposition of the horizontal rectus muscles for congenital/early onset „acquired“ double elevator palsy: a retrospective long term study of 10 consecutive patients. Binocul Vis Strabismus Q 15(1): 29–38.

    PubMed  CAS  Google Scholar 

  2. Simons BD, Saunders TG, Siatkowski RM, Feuer WJ, Lavina AM, Ca H, Munoz M, Flynn JT (1998). Outcome of surgical management of superior oblique palsy: study of 123 cases. Binocul Vis Strabismus Q 13(4): 273–82.

    PubMed  CAS  Google Scholar 

Literatur

  1. Weinshenker et al. The natural history of mutiple sclerosis: a geographically based study. I. Clinical course and disability: Brain 1989; 112:133–146.

    PubMed  Google Scholar 

  2. Curró Dossi B et al. New therapeutic perspectives for demyelinating retrobulbar optic neuritis. Ital J Neurol Sci 1998; 19:45–48.

    PubMed  Google Scholar 

Literatur

  1. Sepehrnia A (1998). Tumoren der Hirnnerven. In: Schlegel U, Westphal M (Hrsg.) Neuroonkologie. Thieme, Stuttgart New York 249–265.

    Google Scholar 

  2. Rock J (2000). Pilocytic Astrocytoma and other indolent Tumors. In: Bernstein M, Berger MS (Hrsg.) Neuro-Oncology. The Essentials. Thieme, New York 319–328.

    Google Scholar 

Literatur

  1. Johnson LN. et al. (2000) Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology 107:521–526.

    PubMed  CAS  Google Scholar 

  2. Ischemic Optic Neuropathy Decompression Trial (2000) Twenty-four-month update. Arch Ophthalmol 118:793–8.

    Google Scholar 

  3. Salomon O. et al. (1999) Role of aspirin in reducing the frequency of second eye involvement in patientes with non-arteritic anterior ischaemic optic neuropathy. Eye 13:357–359.

    PubMed  Google Scholar 

Literatur

  1. Huber A, Kömpf D (1998) Klinische Neuroophthalmologie. Thieme, Stuttgart New York.

    Google Scholar 

Literatur

  1. Dickersin K et al. Surgery for nonarteritic AION. Cochrane Database Syst Rev 2000; 2:CD 001538

    Google Scholar 

  2. IONDT-Trial Group. Ischemic optic neuropathy decompression trial: twenty-four-month update. Arch Ophthalmol 2000; 118:793–798

    Google Scholar 

Literatur

  1. Bartalena I et al. Orbital radiotherapy for Grave’s ophthalmopathy. Thyroid 2002; 12:245–250

    Article  PubMed  Google Scholar 

  2. Korinth MC et al. Follow-up of extended pterional orbital decompression in severe Grave’s ophthalmopathy. Acta Neurochir (Wien) 2002; 144:113–120

    Article  Google Scholar 

Literatur

  1. Kodama H, Mori Y, Kubota K, Iitsuka T, Nakazoto Y, Abe T (1996) Intravenous arginine dramatically improved hyperammonemia in a patient with late-onset ornithine transcarbamylase deficiency. Tohoku J Exp Med 180: 83–86.

    PubMed  CAS  Google Scholar 

  2. Tuchman M, McCullough BA, Yudkoff M (2000) The molecular basis of ornithine transcarbamylase deficiency. Eur J Pediatr 159Suppl.: 196–198.

    Google Scholar 

Literatur

  1. Grundfeld EA. et al. (2000) Adaptation to oscillopsia: a psychophysical and questionnaire investigation. Brain 123:277–90.

    Google Scholar 

Download references

Editor information

Editors and Affiliations

  1. Klinik für Neurologie mit Klinischer Neurophysiologie, Alfried-Krupp-Krankenhaus, Alfried-Krupp-Straße 21, 45131, Essen

    Peter Berlit

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2005). O. In: Berlit, P. (eds) Therapielexikon Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26367-5_15

Download citation

  • DOI: https://doi.org/10.1007/3-540-26367-5_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-67137-4

  • Online ISBN: 978-3-540-26367-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation